English

China Dasheng Biotechnology CO

EDGAR

Quarterly report (10-Q) · filed 2009-05-14

10 filing records in this dataset, filed from 2007-09-19 to 2009-05-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

5.31 million USD

2009-03-31 · USD

Exact inputs and evidence

Revenue: 5308553 USD Source

Operating margin

29.54%

2009-03-31 · %

Exact inputs and evidence

Operating Income: 1567987 USD Source
Revenue: 5308553 USD Source

Operating cash flow

2.98 million USD

2009-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 7762623 USD Source
Operating Cash Flow: 4782894 USD Source

Cash and cash equivalents: 10.4 million USD 2009-03-31 Source
Exact value

10413273 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

20.9 million USD

2008-04-01 – 2009-03-31

Exact inputs and evidence

Revenue: 16294163 USD · 2007-07-01 – 2008-06-30 Source
Revenue: 11421215 USD · 2007-07-01 – 2008-03-31 Source
Revenue: 5107515 USD · 2008-07-01 – 2008-09-30 Source
Revenue: 5660793 USD · 2008-10-01 – 2008-12-31 Source
Revenue: 5308553 USD · 2009-01-01 – 2009-03-31 Source

Net income

6.41 million USD

2008-04-01 – 2009-03-31

Exact inputs and evidence

Net income: 4638336 USD · 2007-07-01 – 2008-06-30 Source
Net income: 2596845 USD · 2007-07-01 – 2008-03-31 Source
Net income: 1328272 USD · 2008-07-01 – 2008-09-30 Source
Net income: 1731555 USD · 2008-10-01 – 2008-12-31 Source
Net income: 1304673 USD · 2009-01-01 – 2009-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2009-05-14.

Financial data available through: 2008-06-30.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 2008-06-30
Operating income: 2 of 11 periods available· newest 2008-06-30
Net income: 2 of 11 periods available· newest 2008-06-30
Operating cash flow: 2 of 11 periods available· newest 2008-06-30
Capital expenditure: 2 of 11 periods available· newest 2008-06-30
Total assets: 2 of 11 periods available· newest 2008-06-30
Total liabilities: 1 of 11 periods available· newest 2007-06-30
Current assets: 2 of 11 periods available· newest 2008-06-30
Current liabilities: 2 of 11 periods available· newest 2008-06-30
Cash and cash equivalents: 2 of 11 periods available· newest 2008-06-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+63.6%

Prior period

USD 9.96 million

2006-07-01 – 2007-06-30
Current period

USD 16.29 million

2007-07-01 – 2008-06-30

Exact inputs and evidence

16294163 − 9961792 = 6332371 USD

9961792 USD · 2006-07-01 – 2007-06-30
Inspect prior input Prior source
16294163 USD · 2007-07-01 – 2008-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · China Dasheng Biotechnology CO · 2008-06-30 China Dasheng Biotechnology CO (edgar:1393067) Year-over-year change in Revenue: 6332371 USD Concept: fundies:Revenue Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-04T12:25:15Z Snapshot: bec2c9615b846706171a2c5119fea332eea44217f0cf30eb055a1dfabc003251 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393067?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 16294163 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393067/0001406774-08-000124.txt#5673 Input fundies:Revenue: 9961792 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393067/0001406774-08-000124.txt#5673
The citation records this snapshot. The page link may show a newer release later.
Net income
+132.9%

Prior period

USD 1.99 million

2006-07-01 – 2007-06-30
Current period

USD 4.64 million

2007-07-01 – 2008-06-30

Exact inputs and evidence

4638336 − 1991534 = 2646802 USD

1991534 USD · 2006-07-01 – 2007-06-30
Inspect prior input Prior source
4638336 USD · 2007-07-01 – 2008-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · China Dasheng Biotechnology CO · 2008-06-30 China Dasheng Biotechnology CO (edgar:1393067) Year-over-year change in Net income: 2646802 USD Concept: fundies:NetIncome Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-04T12:25:15Z Snapshot: bec2c9615b846706171a2c5119fea332eea44217f0cf30eb055a1dfabc003251 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393067?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 4638336 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393067/0001406774-08-000124.txt#9425 Input fundies:NetIncome: 1991534 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393067/0001406774-08-000124.txt#9425
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+943.1%

Prior period

USD 392,855

2006-07-01 – 2007-06-30
Current period

USD 4.1 million

2007-07-01 – 2008-06-30

Exact inputs and evidence

4097932 − 392855 = 3705077 USD

392855 USD · 2006-07-01 – 2007-06-30
Inspect prior input Prior source
4097932 USD · 2007-07-01 – 2008-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · China Dasheng Biotechnology CO · 2008-06-30 China Dasheng Biotechnology CO (edgar:1393067) Year-over-year change in Operating cash flow: 3705077 USD Concept: fundies:OperatingCashFlow Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-04T12:25:15Z Snapshot: bec2c9615b846706171a2c5119fea332eea44217f0cf30eb055a1dfabc003251 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393067?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 4097932 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393067/0001406774-08-000124.txt#9884 Input fundies:OperatingCashFlow: 392855 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393067/0001406774-08-000124.txt#9884
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-48.4%

Prior period

USD 59,411

2006-07-01 – 2007-06-30
Current period

USD 30,683

2007-07-01 – 2008-06-30

Exact inputs and evidence

30683 − 59411 = -28728 USD

59411 USD · 2006-07-01 – 2007-06-30
Inspect prior input Prior source
30683 USD · 2007-07-01 – 2008-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · China Dasheng Biotechnology CO · 2008-06-30 China Dasheng Biotechnology CO (edgar:1393067) Year-over-year change in Capital expenditure: -28728 USD Concept: fundies:CapitalExpenditure Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-04T12:25:15Z Snapshot: bec2c9615b846706171a2c5119fea332eea44217f0cf30eb055a1dfabc003251 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393067?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 30683 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393067/0001406774-08-000124.txt#9966 Input fundies:CapitalExpenditure: 59411 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393067/0001406774-08-000124.txt#9966
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2008 2007-07-01 – 2008-06-30

Revenue USD 16.29 million 100% of revenue
Cost of revenue USD 8.79 million 54% of revenue
Operating expenses USD 2.43 million 15% of revenue
Operating income USD 5.07 million 31% of revenue
Tax, interest and other Derived USD 436,636 2.7% of revenue
Net income USD 4.64 million 28% of revenue

Cash

Operating cash flow USD 4.1 million 25% of revenue
Capital expenditure USD 30,683 0.2% of revenue
Free cash flow Derived USD 4.07 million 25% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2007 20%72%
2008 28%69%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2007 2006-07-01 – 2007-06-30	9961792	7211370 Derived	2750422	758888 Derived	1991534	333444 Derived	Source 2006-07-01 – 2007-06-30: 9961792 USD Inspect Revenue Open source 2006-07-01 – 2007-06-30: 2750422 USD Inspect Operating Income Open source 2006-07-01 – 2007-06-30: 1991534 USD Inspect Net Income Open source 2006-07-01 – 2007-06-30: 392855 USD Inspect Operating Cash Flow Open source 2006-07-01 – 2007-06-30: 59411 USD Inspect Capital Expenditure Open source
2008 2007-07-01 – 2008-06-30	16294163	11219191 Derived	5074972	436636 Derived	4638336	4067249 Derived	Source 2007-07-01 – 2008-06-30: 16294163 USD Inspect Revenue Open source 2007-07-01 – 2008-06-30: 5074972 USD Inspect Operating Income Open source 2007-07-01 – 2008-06-30: 4638336 USD Inspect Net Income Open source 2007-07-01 – 2008-06-30: 4097932 USD Inspect Operating Cash Flow Open source 2007-07-01 – 2008-06-30: 30683 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 16.3M 2008

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-06-30	Revenue	9961792	Revenue: 9961792 Open source
20082008-06-30	Revenue	16294163	Revenue: 16294163 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

63.6% 2008

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20072007-06-30	Year over year	No prior comparable period	Revenue: 9961792 Open source
20082008-06-30	Year over year	63.6%	Revenue: 16294163 Open source Revenue: 9961792 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 31.1% 2008

Net margin 28.5% 2008

Free cash flow margin 25% 2008

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20072007-06-30	Operating margin	27.6%	Operating Income: 2750422 Open source Revenue: 9961792 Open source
20082008-06-30	Operating margin	31.1%	Operating Income: 5074972 Open source Revenue: 16294163 Open source
20072007-06-30	Net margin	20%	Net Income: 1991534 Open source Revenue: 9961792 Open source
20082008-06-30	Net margin	28.5%	Net Income: 4638336 Open source Revenue: 16294163 Open source
20072007-06-30	Free cash flow margin	3.3%	Revenue: 9961792 Open source Operating Cash Flow: 392855 Open source Capital Expenditure: 59411 Open source
20082008-06-30	Free cash flow margin	25%	Revenue: 16294163 Open source Operating Cash Flow: 4097932 Open source Capital Expenditure: 30683 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 4.1M 2008

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-06-30	Operating cash flow	392855	Operating Cash Flow: 392855 Open source
20082008-06-30	Operating cash flow	4097932	Operating Cash Flow: 4097932 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 4.1M 2008

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-06-30	Free cash flow	333444	Operating Cash Flow: 392855 Open source Capital Expenditure: 59411 Open source
20082008-06-30	Free cash flow	4067249	Operating Cash Flow: 4097932 Open source Capital Expenditure: 30683 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

40.7% 2007

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20072007-06-30	Liabilities / assets	40.7%	Total Liabilities: 6258000 Open source Total Assets: 15391001 Open source
2008-06-30	Liabilities / assets	Not reported	Total Assets: 20253041 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

5.52× 2008

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20072007-06-30	Current assets / current liabilities	3.67×	Current Assets: 9174125 Open source Current Liabilities: 2497161 Open source
20082008-06-30	Current assets / current liabilities	5.52×	Current Assets: 8470636 Open source Current Liabilities: 1535143 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2007 2006-07-01 – 2007-06-30	USD 1.99 million Exact value Exact value: 1991534 USD 2006-07-01 – 2007-06-30: 1991534 USD Inspect Net Income Open source Share or cite Citation for Net Income · China Dasheng Biotechnology CO · 2007-06-30 China Dasheng Biotechnology CO (edgar:1393067) Net Income: 1991534 USD Concept: fundies:NetIncome Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-04T12:25:15Z Snapshot: bec2c9615b846706171a2c5119fea332eea44217f0cf30eb055a1dfabc003251 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393067/explain?concept=fundies%3ANetIncome&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:NetIncome: 1991534 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393067/0001406774-08-000124.txt#9425 The citation records this snapshot. The page link may show a newer release later.	USD 392,855 Exact value Exact value: 392855 USD 2006-07-01 – 2007-06-30: 392855 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · China Dasheng Biotechnology CO · 2007-06-30 China Dasheng Biotechnology CO (edgar:1393067) Operating Cash Flow: 392855 USD Concept: fundies:OperatingCashFlow Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-04T12:25:15Z Snapshot: bec2c9615b846706171a2c5119fea332eea44217f0cf30eb055a1dfabc003251 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393067/explain?concept=fundies%3AOperatingCashFlow&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 392855 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393067/0001406774-08-000124.txt#9884 The citation records this snapshot. The page link may show a newer release later.	USD 59,411 Exact value Exact value: 59411 USD 2006-07-01 – 2007-06-30: 59411 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · China Dasheng Biotechnology CO · 2007-06-30 China Dasheng Biotechnology CO (edgar:1393067) Capital Expenditure: 59411 USD Concept: fundies:CapitalExpenditure Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-04T12:25:15Z Snapshot: bec2c9615b846706171a2c5119fea332eea44217f0cf30eb055a1dfabc003251 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393067/explain?concept=fundies%3ACapitalExpenditure&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 59411 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393067/0001406774-08-000124.txt#9966 The citation records this snapshot. The page link may show a newer release later.	USD 333,444 Calculation and evidence 392855 − 59411 USD Exact free cash flow: 333444 USD 2006-07-01 – 2007-06-30: 392855 USD · Inspect Operating Cash Flow · Source 2006-07-01 – 2007-06-30: 59411 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · China Dasheng Biotechnology CO · 2007-06-30 China Dasheng Biotechnology CO (edgar:1393067) Free cash flow: 333444 USD Concept: free-cash-flow Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-04T12:25:15Z Snapshot: bec2c9615b846706171a2c5119fea332eea44217f0cf30eb055a1dfabc003251 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393067?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 392855 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393067/0001406774-08-000124.txt#9884 Input fundies:CapitalExpenditure: 59411 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393067/0001406774-08-000124.txt#9966 The citation records this snapshot. The page link may show a newer release later.
2008 2007-07-01 – 2008-06-30	USD 4.64 million Exact value Exact value: 4638336 USD 2007-07-01 – 2008-06-30: 4638336 USD Inspect Net Income Open source Share or cite Citation for Net Income · China Dasheng Biotechnology CO · 2008-06-30 China Dasheng Biotechnology CO (edgar:1393067) Net Income: 4638336 USD Concept: fundies:NetIncome Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-04T12:25:15Z Snapshot: bec2c9615b846706171a2c5119fea332eea44217f0cf30eb055a1dfabc003251 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393067/explain?concept=fundies%3ANetIncome&period=2008-06-30&surface=latest&period_type=duration&start=2007-07-01&unit=USD&dimensions= Input fundies:NetIncome: 4638336 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393067/0001406774-08-000124.txt#9425 The citation records this snapshot. The page link may show a newer release later.	USD 4.1 million Exact value Exact value: 4097932 USD 2007-07-01 – 2008-06-30: 4097932 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · China Dasheng Biotechnology CO · 2008-06-30 China Dasheng Biotechnology CO (edgar:1393067) Operating Cash Flow: 4097932 USD Concept: fundies:OperatingCashFlow Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-04T12:25:15Z Snapshot: bec2c9615b846706171a2c5119fea332eea44217f0cf30eb055a1dfabc003251 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393067/explain?concept=fundies%3AOperatingCashFlow&period=2008-06-30&surface=latest&period_type=duration&start=2007-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4097932 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393067/0001406774-08-000124.txt#9884 The citation records this snapshot. The page link may show a newer release later.	USD 30,683 Exact value Exact value: 30683 USD 2007-07-01 – 2008-06-30: 30683 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · China Dasheng Biotechnology CO · 2008-06-30 China Dasheng Biotechnology CO (edgar:1393067) Capital Expenditure: 30683 USD Concept: fundies:CapitalExpenditure Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-04T12:25:15Z Snapshot: bec2c9615b846706171a2c5119fea332eea44217f0cf30eb055a1dfabc003251 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393067/explain?concept=fundies%3ACapitalExpenditure&period=2008-06-30&surface=latest&period_type=duration&start=2007-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 30683 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393067/0001406774-08-000124.txt#9966 The citation records this snapshot. The page link may show a newer release later.	USD 4.07 million Calculation and evidence 4097932 − 30683 USD Exact free cash flow: 4067249 USD 2007-07-01 – 2008-06-30: 4097932 USD · Inspect Operating Cash Flow · Source 2007-07-01 – 2008-06-30: 30683 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · China Dasheng Biotechnology CO · 2008-06-30 China Dasheng Biotechnology CO (edgar:1393067) Free cash flow: 4067249 USD Concept: free-cash-flow Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-04T12:25:15Z Snapshot: bec2c9615b846706171a2c5119fea332eea44217f0cf30eb055a1dfabc003251 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1393067?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 4097932 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393067/0001406774-08-000124.txt#9884 Input fundies:CapitalExpenditure: 30683 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1393067/0001406774-08-000124.txt#9966 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

10 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-04. Source filing dates and reporting periods are shown separately.

Identifiers: 0001393067, 1393067, edgar:1393067

Also known as Max Nutrition, Inc.

China Dasheng Biotechnology CO

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2008 2007-07-01 – 2008-06-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation